NSE · TRIGYN
Trigyn Technologies Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹70 Cr with net profit ₹5 Cr — a 6.9% net margin, versus -6.53% the period before.
Shareholding
As of 2026-09-30
- Promoter44.51%
- Public55.33%
- FII0.15%
- DII0.01%
31,291 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.09× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Computers - Software - Medium / Small · ranked #133 of 290 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| PB FinTech Limited | ₹44,748 Cr | 55.54 | 5.76 | 10.36% | 10.2% |
| Inventurus Knowledge Solutions Ltd. | ₹28,446 Cr | 37.25 | 8.52 | 23.97% | 19.25% |
| Tata Technologies Limited | ₹27,029 Cr | 41.17 | 7.04 | 17.14% | 8.93% |
| Tata Elxsi Limited | ₹24,019 Cr | 33.34 | 8.24 | 24.73% | 16.65% |
| Affle 3i Limited | ₹22,736 Cr | 45.74 | 4.93 | 11.75% | 16.72% |
| Firstsource Solutions Ltd. | ₹20,762 Cr | 24.33 | 4.25 | 17.49% | 6.79% |
| Sagility Limited | ₹20,345 Cr | 19.15 | 1.99 | 10.04% | 12.84% |
| Pine Labs Limited | ₹18,759 Cr | 116.04 | 3.12 | 2.66% | 5.35% |
| eClerx Services Ltd. | ₹15,054 Cr | 20.73 | 5.15 | 24.91% | 16.07% |
| KPIT Technologies Ltd. | ₹14,804 Cr | 25.7 | 4.01 | 14.49% | 7.98% |
| Trigyn Technologies Ltd.(this company) | ₹189 Cr | 10.33 | 0.22 | 2.09% | 1.66% |
AI analysis
AI-generated · google/gemini-2.5-flashTrigyn Technologies Ltd. is listed with a market capitalization of Rs 166 Cr. The company reported revenue of Rs 915.79 Cr with a profit margin of 20.3%. Its earnings per share (EPS) stands at Rs 0.68, and it has a book value of Rs 258.79. The debt-to-equity ratio is 0.01.
Positives
- +The company's debt-to-equity ratio is low at 0.01.
- +The profit margin for the latest annual period stood at 20.3%.
Negatives
- −Revenue growth for the latest financial year was negative at -29.8%.
- −Return on capital employed (ROCE) is low at 2.22%.
- −The company is under LT-ASM surveillance, indicating regulatory concerns.
Financial Performance
Trigyn Technologies Ltd. reported annual revenue of Rs 915.79 Cr in Mar 2025. This represents a revenue growth of -29.8%. The company’s net profit for the same period was Rs 11.7694 Cr, with a profit margin of 20.3%.
Profitability & Returns
The company's earnings per share (EPS) for the latest reported period is Rs 0.68. Return on equity (ROE) is 26.4%, while return on capital employed (ROCE) is 2.22%. The annual net profit for Mar 2025 was Rs 11.7694 Cr.
Balance Sheet
Trigyn Technologies Ltd. has a book value per share of Rs 258.79. The company maintains a low debt-to-equity ratio of 0.01, indicating minimal reliance on borrowed capital. There is no dividend yield reported for the company.
Ownership & Pledges
As of June 30, 2026, promoters held 44.5072% of the company's shares. Public shareholding was 55.3584%, FIIs held 0.1247%, and DIIs held 0.0097%. Institutions collectively held 0.1344%. There are no promoter shares pledged reported as of the latest disclosure.
Regulatory & Surveillance
Trigyn Technologies Ltd. is currently under LT-ASM (Long Term Additional Surveillance Measure) Stage 1. This classification indicates heightened monitoring by regulatory authorities, affecting market transactions for the stock.
Data as of — price: 2026-11-07 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.